Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Predisposition to hematopoietic malignancies by deleterious germline CHEK2 variants

ABSTRACT: Predisposition to hematopoietic malignancies by deleterious germline CHEK2 variants

PROVIDER: PRJNA1119518 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

Predisposition to hematopoietic malignancies by deleterious germline CHEK2 variants

Project description:The role of germline CHEK2 variants in hematopoietic malignancies (HMs) is poorly understood. We examined pathogenic/likely pathogenic (P/LP) CHEK2 variants in a hereditary hematopoietic malignancy (HHM) and solid tumor risk cohorts, the UK Biobank, public acute myeloid leukemia (AML) datasets, and a knock-in mouse model. This submission is for the data from Chek2 p.161T mice,sorted CD34+ Bone Marrow cells,Bulk RNA Sequencing.

2025-05-01 | GSE268966 | GEO

Project description:Predisposition to hematopoietic malignancies by deleterious germline CHEK2 variants

| PRJNA1119484 | ENA

Defective RNA helicase genes underlie predisposition to colorectal and hematological malignancies

Project description:Background: Causative genes are mostly unknown for the mismatch repair-proficient category of familial colorectal cancers designated as FCCTX. Recent evidence suggests shared susceptibility factors between colorectal and hematological malignancies. Study design: We investigated 28 FCCTX families by exome sequencing, supplemented with whole genome sequencing, RNA-sequencing, and tumor studies to identify the predisposing genes. Guided by the findings, germline and somatic exomes of ~400 patients with acute leukemia, myelodysplastic syndrome, and myeloma were subsequently examined. Results: A family with hematological and solid malignancies revealed a truncating variant in the DEAH-box RNA helicase gene DHX40 co-segregating with disease in seven family members. Neoplastic tissues revealed no apparent “second hit”, implying a haploinsufficiency model of tumorigenesis. DHX40 siRNA-treated cell lines exhibited a 13% increase in aberrantly spliced transcripts vs. GAPDH-siRNA or non-target siRNA-treated cells. Two additional families showed truncating germline variants in the TDRD9 and TDRD5 genes encoding Tudor domain-containing RNA-binding proteins. In the hospital-based hematological series, 18% of germline and 28% of somatic exomes revealed possibly pathogenic DEAD/H box gene variants, including somatic variants of DHX40 in four. Conclusions: This study identifies DHX40, TDRD9, and TDRD5 as novel candidate genes for FCCTX predisposition. In the family segregating the truncating DHX40 variant, two carriers had hematological neoplasia, suggesting possible analogy to DDX41, a DEAD-box RNA helicase gene previously linked to myeloid malignancies. Our findings emphasize aberrant RNA metabolism behind FCCTX and hematological neoplasia.

2023-11-08 | GSE228991 | GEO

STAG1 Mutations in Genetic Predisposition to Childhood hematological malignancies

Project description:STAG1 Mutations in Genetic Predisposition to Childhood hematological malignancies

| PRJEB52940 | ENA

Germline DNA Methylation Associated with Breast Cancer Predisposition

Project description:Germline DNA Methylation Associated with Breast Cancer Predisposition

| PRJNA492711 | ENA

Germline DNA Methylation Associated with Breast Cancer Predisposition

Project description:Germline DNA Methylation Associated with Breast Cancer Predisposition

| PRJNA492712 | ENA

Exome sequencing data analysis to characterize rare germline copy number variants involved in colorectal cancer predisposition

Project description:Colorectal cancer (CRC) represents the third most common cancer worldwide. Next generation sequencing (NGS) appearance has allowed us to produce huge amount of data and, in order to fully exploit its usage, copy number variants (CVN) detection software have been developed. In this study, we analyze germline DNA whole-exome sequencing (WES) data from 38 families with strong CRC aggregation without alterations in known hereditary genes to detect rare candidate CNVs to CRC predisposition using ExomeDepth and CoNIFER tools. Variants shared between family members were compared to Database of Genomic Variants (DGV) catalogue and our Spanish database. CNVs finally selected were validated and segregation analysis were performed using Comparative Genome Hybridization (CGH). Gene expression arrays and qRT-PCR were conducted in both germline and tumor cDNA to check possible effects at transcription level. Immunohistochemistry (IHC) studies were also carried out. Whith this, 21 candidate CNV corresponding to 16 duplications and 5 deletions were detected by calling tools. After multiple filtering steps, only the duplication in chromosome 1 in family 7 stood out as interesting. Validation by CGH confirmed the duplication and correct family segregation. TTF2, TRIM45, VTCN1 and miR942 are embedded in chromosome 1 duplication. Expression studies pointed to TTF2 and miR942 overexpression in carriers, and tumor IHC showed TTF2 protein overexpression and underexpression of the TMEM158 protein. Also known as RIS1, TMEM158 is a predicted target of miR942 and has been claimed to be a candidate tumor-supressor. All in all, chromosome 1 duplication may correspond to the mutational event involved in CRC predisposition in the carrier family by overexpressing TTF2 and miR942, leading to TMEM158 underexpression. Keywords: colorectal cancer, next generation sequencing, copy number variant, duplication, predisposition.

2019-03-01 | GSE96597 | GEO

Mutation in familial platelet disorder with predisposition to myeloid malignancies

Project description:Mutation in familial platelet disorder with predisposition to myeloid malignancies

| PRJEB27365 | ENA

The mammalian germline corrects deleterious effects of endocrine disruptors

Project description:The mammalian germline corrects deleterious effects of endocrine disruptors

| PRJNA255525 | ENA

Germline RUNX1 Variation and Predisposition to Childhood Acute Lymphoblastic

Project description:Germline RUNX1 Variation and Predisposition to Childhood Acute Lymphoblastic

| PRJNA737803 | ENA